CPH expands its footprint with new product launch and entry into Eastern Europe
Finfeed
Archived
May 21, 2021
Creso Pharma (ASX: CPH) will enter the Polish animal health market after signing a Letter of Intent with Polvet Healthcare Teodorowski Spółka Jawna. It has also finalised the development of anibidiol® swine, a new and innovative hemp flour and oat bran based complementary feed product.